Björn E. Wahlin

A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study

Constantine S. Tam, Stephen Opat, Shirley D’Sa et al. · Blood · 2020 · 432 citations · Full text

A Unifying Microenvironment Model in Follicular Lymphoma: Outcome Is Predicted by Programmed Death-1–Positive, Regulatory, Cytotoxic, and Helper T Cells and Macrophages

Björn E. Wahlin, Mohit Aggarwal, Santiago Montes‐Moreno et al. · Clinical Cancer Research · 2010 · 188 citations

Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML

Andreas T. Björklund, Mattias Carlsten, Ebba Sohlberg et al. · Clinical Cancer Research · 2018 · 182 citations · Full text

Clinical significance of the WHO grades of follicular lymphoma in a population‐based cohort of 505 patients with long follow‐up times

Björn E. Wahlin, Olav Erich Yri, Eva Kimby et al. · British Journal of Haematology · 2011 · 149 citations

CD8+ T-Cell Content in Diagnostic Lymph Nodes Measured by Flow Cytometry Is a Predictor of Survival in Follicular Lymphoma

Björn E. Wahlin, Birgitta Sander, Birger Christensson et al. · Clinical Cancer Research · 2007 · 146 citations